These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1229 related items for PubMed ID: 16083542

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer's disease: a post hoc analysis.
    Farlow MR, Alva G, Meng X, Olin JT.
    Curr Med Res Opin; 2010 Feb; 26(2):263-9. PubMed ID: 19929593
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease.
    Jones RW, Soininen H, Hager K, Aarsland D, Passmore P, Murthy A, Zhang R, Bahra R.
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):58-67. PubMed ID: 14716700
    [Abstract] [Full Text] [Related]

  • 9. Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology.
    Touchon J, Bergman H, Bullock R, Rapatz G, Nagel J, Lane R.
    Curr Med Res Opin; 2006 Jan; 22(1):49-59. PubMed ID: 16393430
    [Abstract] [Full Text] [Related]

  • 10. An open-label, comparative study of rivastigmine, donepezil and galantamine in a real-world setting.
    Aguglia E, Onor ML, Saina M, Maso E.
    Curr Med Res Opin; 2004 Nov; 20(11):1747-52. PubMed ID: 15537474
    [Abstract] [Full Text] [Related]

  • 11. Effects of switching from an AChE inhibitor to a dual AChE-BuChE inhibitor in patients with Alzheimer's disease.
    Bartorelli L, Giraldi C, Saccardo M, Cammarata S, Bottini G, Fasanaro AM, Trequattrini A, Upgrade Study Group.
    Curr Med Res Opin; 2005 Nov; 21(11):1809-18. PubMed ID: 16307702
    [Abstract] [Full Text] [Related]

  • 12. Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years.
    Farlow MR, Lilly ML, ENA713 B352 Study Group.
    BMC Geriatr; 2005 Jan 19; 5():3. PubMed ID: 15659242
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A, Imai Y, Tago H, Asada T, Shigeta M, Iwamoto T, Takita M, Arimoto I, Koma H, Takase T, Ohbayashi T.
    Dement Geriatr Cogn Disord; 2009 Jan 19; 27(3):232-9. PubMed ID: 19246907
    [Abstract] [Full Text] [Related]

  • 15. Cholinesterase inhibitors for Alzheimer's disease.
    Birks J.
    Cochrane Database Syst Rev; 2006 Jan 25; 2006(1):CD005593. PubMed ID: 16437532
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a "real world" study.
    Mossello E, Tonon E, Caleri V, Tilli S, Cantini C, Cavallini MC, Bencini F, Mecacci R, Marini M, Bardelli F, Sarcone E, Razzi E, Biagini CA, Masotti G.
    Arch Gerontol Geriatr Suppl; 2004 Jan 25; (9):297-307. PubMed ID: 15207427
    [Abstract] [Full Text] [Related]

  • 17. Predicting time to nursing home placement based on activities of daily living scores--a modelling analysis using data on Alzheimer's disease patients receiving rivastigmine or donepezil.
    Hatoum HT, Thomas SK, Lin SJ, Lane R, Bullock R.
    J Med Econ; 2009 Jun 25; 12(2):98-103. PubMed ID: 19492974
    [Abstract] [Full Text] [Related]

  • 18. Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials.
    Winblad B, Black SE, Homma A, Schwam EM, Moline M, Xu Y, Perdomo CA, Swartz J, Albert K.
    Curr Med Res Opin; 2009 Nov 25; 25(11):2577-87. PubMed ID: 19735164
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.